VanEck Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
62.86 +0.59  +0.95% NASDAQ Jan 12, 20:00 Delayed 2m USD
View Full Chart
PPH Price Chart

PPH Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 6.68% 6.68% 5.99% 25
3M 8.48% 8.45% 5.00% 19
6M 8.43% 8.43% 9.30% 54
YTD 5.99% 5.93% 5.08% 16
1Y 21.45% 21.50% 25.66% 65
3Y 0.47% 0.48% 7.16% 97
5Y 10.78% 10.80% 17.28% 99
10Y -- -- 12.17% --
As of Jan. 12, 2018. Returns for periods of 1 year and above are annualized.

PPH Asset Allocation

Type % Net % Long % Short
Cash 0.02% 0.02% 0.00
Stock 99.92% 99.92% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.05% 0.05% 0.00
As of Jan. 12, 2018

PPH Region Exposure

Americas 68.29%
North America 68.29%
Latin America 0.00
Greater Europe 31.71%
United Kingdom 11.45%
Europe Developed 14.04%
Europe Emerging 0.00
Africa/Middle East 6.22%
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00
As of Jan. 12, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Jan. 12, 2018

PPH Stock Market Capitalization

Giant 47.29%
Large 24.15%
Medium 22.94%
Small 5.62%
Micro 0.00
As of Jan. 12, 2018

PPH Stock Style Exposure

Large Cap Value 34.88%
Large Cap Blend 22.92%
Large Cap Growth 13.64%
Mid Cap Value 16.22%
Mid Cap Blend 0.00
Mid Cap Growth 6.72%
Small Cap Value 2.60%
Small Cap Blend 1.09%
Small Cap Growth 1.93%
As of Jan. 12, 2018
View More Holdings

PPH Top 10 Holdings

Symbol Name % Weight Price % Chg
TEVA Teva Pharmaceutical Industries Ltd ADR 6.21% 22.07 +1.52%
VRX Valeant Pharmaceuticals International Inc 5.46% 23.84 +0.13%
MYL Mylan NV 5.10% 46.90 +0.41%
AZN AstraZeneca PLC ADR 4.97% 35.65 +0.71%
GSK GlaxoSmithKline PLC ADR 4.85% 37.50 +1.79%
MRK Merck & Co Inc 4.84% 58.66 +1.84%
ABBV AbbVie Inc 4.74% 100.34 +1.08%
NVO Novo Nordisk A/S ADR 4.73% 55.04 +0.15%
NVS Novartis AG ADR 4.66% 86.65 +1.14%
SNY Sanofi SA ADR 4.65% 44.78 +1.75%
As of Jan. 12, 2018
Advertisement

PPH One Page Reports

PPH Basic Info

Style
Equity Style Large Cap/Value
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Van Eck
Benchmark Index
MVIS US Listed Pharmaceutical 25 NR USD
100.0%

PPH Manager Info

Name Tenure
George Chao 5.87 yrs
Hao-Hung (Peter) Liao 5.87 yrs

PPH Net Fund Flows

1M 8.549M
3M -8.239M
6M 347457.0
YTD -18.89M
1Y -18.89M
3Y -16.31M
5Y 13.18M
10Y --
As of Dec. 31, 2017

PPH Risk Info

Beta (5Y) 0.9614
Max Drawdown (All) 29.88%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.367
30-Day Rolling Volatility 12.22%
Daily Value at Risk (VaR) 1% (All) 2.29%
Monthly Value at Risk (VaR) 1% (All) 8.93%

PPH Fundamentals

Dividend Yield TTM (1-12-18) 1.81%
SEC Yield (10-30-15) 1.82%
Weighted Average PE Ratio 19.63
Weighted Average Price to Sales Ratio 0.9711
Weighted Average Price to Book Ratio 2.748
Weighted Median ROE 23.12%
Weighted Median ROA 5.29%
Forecasted Dividend Yield 2.52%
Forecasted PE Ratio 18.23
Forecasted Price to Sales Ratio 0.9168
Forecasted Price to Book Ratio 2.103
Number of Holdings 27
As of Jan. 12, 2018

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 7.22%
Forecasted Book Value Growth 4.45%
Forecasted Cash Flow Growth 4.67%
Forecasted Earnings Growth -5.91%
Forecasted Revenue Growth 8.05%
As of Jan. 12, 2018

PPH Comparables

Edit

PPH Attributes

Key Dates
Inception Date 12/20/2011
Termination Date
Last Annual Report Date 9/30/2017
Last Prospectus Date 3/10/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

PPH Excel Add-In Codes

  • Name: =YCI("PPH","name")
  • Broad Asset Class: =YCI("PPH", "broad_asset_class")
  • Broad Category: =YCI("PPH", "broad_category_group")
  • Prospectus Objective: =YCI("PPH", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.